Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
04/2012
04/04/2012EP1914225B1 Display device comprising salt molten at room temperature
04/04/2012EP1893583B1 Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
04/04/2012EP1583529B9 Amino acid phenoxy ethers, their preparation and uses
04/04/2012CN1950347B 作为酪氨酸激酶抑制剂的2-氨基芳基噁唑化合物 As the tyrosine kinase inhibitors 2-aryl-oxazole compounds
04/04/2012CN102399200A 一种利用悬浮结晶法制备利奈唑胺晶型Ⅰ的方法 Preparation of a use of suspended crystalline polymorphs of linezolid method Ⅰ
04/04/2012CN101328156B 含1,3二杂五元环的异羟肟酸类衍生物及其用途 Containing 1,3 hetero five-membered ring hydroxamic acid derivatives and their use
04/03/2012US8148533 Ionic liquids having melting points below about 100 C formed by reaction of a heterocyclic amine with about 2.8 and about 3.2 moles of anhydrous hydrogen fluoride per mole of amine nitrogen. Electrochemical devices having nonaqueous electrolytes containing the ionic liquids are disclosed and sio2 etch
04/03/2012US8148414 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
04/03/2012CA2566464C Synthesis of tetracyclines and analogues thereof
04/03/2012CA2505427C Bicyclic-substituted amines as histamine-3 receptor ligands
03/2012
03/29/2012US20120077854 Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4)
03/29/2012DE102011083361A1 Preparing bis- or oligo-oxazolidines, useful e.g. as catalyst or coating material, and as crosslinking agents in adhesive, comprises reacting oxazolidines having a hydroxy group, with organic carbonates in presence of a catalyst
03/28/2012EP2433932A1 Prophylactic And/Or Therapeutic Agent For Hyperlipidemia
03/28/2012CN102391222A Novel hydroxamates as therapeutic agents
03/27/2012US8143417 Method for the preparation of zolmitriptan
03/27/2012US8143416 Alternative synthesis of renin inhibitors and intermediates thereof
03/27/2012CA2465883C Resin composition
03/22/2012WO2012035305A1 Bioactive alkaloids
03/22/2012US20120071526 Compounds for the treatment of metabolic disorders
03/22/2012US20120071524 Compounds for treatment of cancer
03/21/2012EP2430004A2 Novel oxazolidinone derivatives and their use as orexin receptor antagonists
03/21/2012EP2188254B1 Novel bradykinin b1-antagonists
03/21/2012EP2176245B1 Process for the separation of amine conjugated lipids
03/21/2012EP1996563B1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes
03/21/2012CN1989115B Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses
03/21/2012CN102388022A Hydrazide compound and use of the same in pest control
03/21/2012CN102379872A Compounds, compositions and methods of inhibiting a-synuclein toxicity
03/21/2012CN101687800B Glucokinase activator
03/20/2012US8138351 Treatment of duchenne muscular dystrophy
03/20/2012US8138182 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
03/20/2012CA2401693C 3-aza-6,8-dioxabicyclo[3.2.1]octanes and analogues and combinatorial libraries
03/15/2012US20120065237 Methods for treating transthyretin amyloid diseases
03/15/2012US20120065206 Compounds for treating proliferative disorders
03/15/2012US20120065195 Compounds for treating neurodegenerative diseases
03/15/2012US20120064032 Novel hydroxamates as therapeutic agents
03/14/2012EP2427441A1 Pmk2 modulators for use in the treatment of cancer
03/14/2012EP2141155B1 Prophylactic and/or therapeutic agent for hyperlipidemia
03/14/2012CN101372481B Method for synthesizing 6-chloro-2-(p-hydroxyl)-phenoxy-benzoxazole
03/14/2012CN101212966B Process for synthesizing a CETP inhibitor
03/13/2012US8134011 Oxazolidinium compounds and use as hydrate inhibitors
03/13/2012US8133911 (R)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them
03/08/2012WO2012029942A1 Cyclic amide derivative
03/08/2012WO2012029630A1 Novel polymer, novel n-carboxy-amino acid anhydride, and method for manufacturing same
03/08/2012WO2012028563A1 Bace inhibitors for use in the treatment of diabetes
03/08/2012CA2810130A1 Heterocyclic compounds as dgat1 inhibitors
03/08/2012CA2809112A1 Cyclic amide derivative
03/07/2012EP2426115A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/07/2012EP2426106A1 Piperidine and Piperazine derivatives for the treatment of tumours
03/07/2012EP1352650B1 Inhibitors against the production and release of inflammatory cytokines
03/07/2012CN101845024B Compound for preparing montelukast sodium
03/06/2012US8129529 UV excitable fluorescent energy transfer dyes
03/01/2012WO2011133661A3 Methods and compositions related to dopaminergic neuronal cells
03/01/2012US20120053342 Method for making carbamates, ureas and isocyanates
02/2012
02/29/2012CN102365271A Heterocyclic compounds as autotaxin inhibitors
02/28/2012US8124778 Tricyclic inhibitors of fatty acid amide hydrolase
02/28/2012US8124772 Intermediate products for producing oxazolidinone-quinolone hybrids
02/28/2012US8124625 Method of enhancing the expression of apolipoprotein AI using olefin derivatives
02/23/2012WO2011140232A3 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
02/23/2012US20120045390 Composition and Methods for the Diagnosis and Treatment of Tumor
02/22/2012EP2420890A1 Positive photosensitive resin composition, method for forming cured film, cured film, organic el display device and liquid crystal display device
02/22/2012EP2419412A1 Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4)
02/22/2012EP0986384B1 Inhibitors of protein isoprenyl transferases
02/21/2012US8119813 Method for preparing enantiomerically enriched N-carboxyanhydride
02/21/2012US8119669 Substituted phenoxy N-alkylated thiazolidinediones as estrogen related receptor-α modulators
02/16/2012WO2012020742A1 Novel heterocyclic derivatives and pharmaceutical composition containing same
02/16/2012WO2012020738A1 Heterocyclic compound and use thereof
02/16/2012US20120040974 Mif modulators
02/16/2012US20120040960 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
02/16/2012US20120040826 Novel herbicides
02/15/2012EP2418202A1 New compounds
02/15/2012EP2417119A2 No-carrier-added nucleophilic ýf-18¨fluorination of aromatic compounds
02/15/2012CN102356068A 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
02/15/2012CN102351808A New method for synthesizing fenoxaprop-P-ethyl
02/15/2012CN102351807A Dibenzyl-1,3-oxazolidine-2-ketone compound and preparation method and application thereof
02/15/2012CN102351806A Chiral oxazoline and synthesis method thereof
02/09/2012US20120035187 Anti-neurodegenerative disease agent
02/09/2012US20120035139 Gamma-amino-butyric acid derivatives as gabab receptor ligands
02/09/2012US20120034678 Diaryl Ethers
02/08/2012EP2415759A1 CETP inhibitors
02/08/2012EP2414340A1 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
02/08/2012EP2414339A1 Kinetic resolution of (4s)-4-phenyl-3-ý5(rs)-(4-fluorophenyl)-5-hydroxypentanoyl¨-1,3 oxazolidin 2-one to (5s) isomer via lipase catalyzed enantioselective esterification of the (5r) isomer
02/08/2012EP2414327A1 Heterocyclic compounds as autotaxin inhibitors
02/08/2012EP2414326A1 Intermediates in the preparation of 1,4-diphenyl azetidinone
02/08/2012EP1722863B1 Microcapsules with uv filter activity and process for producing them
02/08/2012CN102348697A 磺酰胺衍生物 Sulfonamide derivatives
02/08/2012CN102348696A Cyclic carbamate compounds useful in energy-curable compositions
02/08/2012CN101982468B 噁唑烷酮衍生物以及含有该衍生物的药物组合物 Oxazolidinone derivatives and pharmaceutical compositions containing the derivative
02/08/2012CN101747287B 2-氧代-1,3-氧氮杂环戊烷-4-甲酰胺衍生物及其用于制备免疫抑制剂的用途 2-oxo-1,3-oxazolidin-4-carboxamide derivatives and their use for the preparation of an immunosuppressant
02/07/2012US8110591 2-aminoaryloxazole compounds as tyrosine kinase inhibitors
02/02/2012WO2012015693A1 Imidazole derivatives
02/02/2012WO2012013728A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
02/02/2012WO2012013716A1 Bicyclic acetyl-coa carboxylase inhibitors
02/02/2012WO2011057973A9 Oxazoline derivatives for treatment of cns disorders
02/02/2012US20120029185 Novel intermediates in the preparation of 1,4-diphenyl azetidinone
02/02/2012US20120028981 Kinase Knockdown Via Electrophilically Enhanced Inhibitors
02/02/2012US20120028959 Dihydroorotate dehydrogenase inhibitors
02/02/2012US20120028316 Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
02/02/2012CA2806008A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
02/01/2012EP2412372A1 2-Aminooxazole derivatives for use as TRPV1 antagonists for treating i.a. pain, inflammation, neurodegenerative diseases or gastrointestinal diseases
02/01/2012EP2411365A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 210